Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1988-5-5
pubmed:abstractText
The effects of 1-ethyl-4-phenyl-1,2,3,6-tetrahydropyridine (EPTP) on striatal dopamine, cortical norepinephrine and cardiac norepinephrine concentrations in mice were compared to the effects of the 1-methyl analog (MPTP). One week after the last of four daily injections of MPTP into mice, persistent depletion of dopamine and its metabolites in the striatum and of norepinephrine in the frontal cortex was found. EPTP did not produce these effects even at doses up to 4 times those of MPTP. A single dose of MPTP depleted cardiac norepinephrine 24 hrs later in mice. EPTP and the corresponding pyridinium compound (EPP+) depleted cardiac norepinephrine to a similar extent as did MPTP. These results and earlier observations show differences between the characteristics of MPTP-induced depletion of brain catecholamines and those of MPTP-induced depletion of cardiac norepinephrine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0034-5164
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
129-32
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart.
pubmed:affiliation
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285.
pubmed:publicationType
Journal Article, Comparative Study